Fromkin Andrew J.
- SEC CIK
- 0001341896
In the past year, 2 open-market sale filings worth $7.96M and no purchases.
Current role at each company
- IMVT Immunovant, Inc.Directoras of May 29, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $7.96M
- 2 filings
- Net
- −$7.96M
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Fromkin Andrew J. as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| May 29, 2026 (view filing) | May 28 | 1 day | Fromkin Andrew J.Director | SSale | −222.0K | $33.51 | −$7.44M | −74.9%74.4K after | 2 lots |
| Dec 3, 2025 (view filing) | Dec 1 | 2 days | Fromkin Andrew J.Director | SSale | −22.2K | $23.25 | −$517.2K | −20.6%85.9K after | 2 lots10b5-1 |
| Mar 11, 2025 (view filing) | Mar 7 | 4 days | Fromkin Andrew J.Director | SSale | −8.00K | $19.60 | −$156.8K | −8.0%91.9K after | 2 lots10b5-1 |
| Dec 5, 2023 (view filing) | Dec 1 | 4 days | Fromkin Andrew J.Director | SSale | −12.3K | $39.73 | −$490.7K | −12.2%88.7K after | 3 lots10b5-1 |
| Aug 11, 2021 (view filing) | Aug 10 | 1 day | Fromkin Andrew J.Director | PPurchase | +5.50K | $7.90 | +$43.5K | +13.7%45.7K after |